<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
cytx-8k_20180831.htm
</title>
</head>
<!-- NG Converter v5.0.18157.137 -->
<body>

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:16pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form 8-K</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Current Report&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date of Report<font style="font-weight:bold;">&#160;</font>(Date of earliest event reported):<font style="font-weight:bold;">&#160; August 28, 2018</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:180pt;"></td>
<td style="width:180pt;"></td>
<td style="width:180pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">001-34375</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">33-0827593</p></td>
</tr>
<tr style="height:30.95pt;">
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction of Incorporation)</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Commission File</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number)</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer Identification Number)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3020 Callan Road, San Diego, California 92121</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, with zip code)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(858) 458-0900</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Registrant's telephone number, including area code)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">n/a</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="font-style:italic;">see</font> General Instruction A.2. below):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="hangingindent"></a><a name="hangingindent"></a>&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.7pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="&#116;&#97;&#98;&#50;"></a>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.7pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:539.9pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.6pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:539.9pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.6pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="pgbrk"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#070707;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate<font style="letter-spacing:-0.15pt;"> </font>by<font style="letter-spacing:0.3pt;"> </font>check<font style="letter-spacing:-0.1pt;"> </font>mark whether<font style="letter-spacing:0.05pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>registrant<font style="letter-spacing:0.25pt;"> </font>is <font style="color:#171717;">a</font>n<font style="letter-spacing:0.1pt;"> </font>emerging<font style="letter-spacing:-0.1pt;"> </font>growth<font style="letter-spacing:0.15pt;"> </font>company<font style="letter-spacing:0.1pt;"> </font>as<font style="letter-spacing:-0.05pt;"> </font>defined<font style="letter-spacing:-0.1pt;"> </font>in as<font style="letter-spacing:-0.05pt;"> </font>defined<font style="letter-spacing:0.1pt;"> </font>in<font style="letter-spacing:-0.2pt;"> </font>Rule<font style="letter-spacing:0.05pt;"> </font>405<font style="letter-spacing:0.15pt;"> </font>of the<font style="letter-spacing:0.4pt;"> </font>Securities</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:7.22%;text-indent:-0.04%;color:#070707;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Act<font style="letter-spacing:0.35pt;"> </font>of<font style="letter-spacing:1.05pt;"> </font>1933<font style="letter-spacing:-0.9pt;"> </font>(&#167;<font style="letter-spacing:-0.75pt;"> </font>230.405<font style="letter-spacing:0.3pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>this<font style="letter-spacing:0.15pt;"> </font>chapter)<font style="letter-spacing:0.05pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>Rule<font style="letter-spacing:1.1pt;"> </font>12b-2<font style="letter-spacing:-0.8pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:0.4pt;"> </font>Securities<font style="letter-spacing:-0.35pt;"> </font>Exchange<font style="letter-spacing:-0.15pt;"> </font>Act<font style="letter-spacing:0.35pt;"> </font>of<font style="letter-spacing:0.9pt;"> </font>1934<font style="letter-spacing:-0.7pt;"> </font>(&#167;<font style="letter-spacing:-0.75pt;"> </font>240.12b-2<font style="letter-spacing:0.25pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>this<font style="letter-spacing:0.15pt;"> </font>chapter). </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:7.22%;text-indent:0%;color:#070707;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging<font style="letter-spacing:0.2pt;"> </font>growth<font style="letter-spacing:0.15pt;"> </font>company<font style="letter-spacing:0.45pt;"> </font><font style="color:#000000;font-size:11pt;">&#9633;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#070707;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company,<font style="letter-spacing:0.1pt;"> </font>indi<font style="letter-spacing:-0.05pt;">c</font><font style="color:#171717;">a</font>te<font style="letter-spacing:-0.3pt;"> </font>by<font style="letter-spacing:0.3pt;"> </font>check<font style="letter-spacing:-0.25pt;"> </font>mark<font style="letter-spacing:0.35pt;"> </font>if<font style="letter-spacing:-0.15pt;"> </font>the<font style="letter-spacing:-0.15pt;"> </font>registrant<font style="letter-spacing:0.05pt;"> </font>has<font style="letter-spacing:0.2pt;"> </font>elected<font style="letter-spacing:-0.2pt;"> </font>not to use the<font style="letter-spacing:0.2pt;"> </font>e<font style="color:#171717;">x</font>tended<font style="letter-spacing:-0.25pt;"> </font>transition<font style="letter-spacing:-0.15pt;"> </font>period<font style="letter-spacing:0.4pt;"> </font>for complying<font style="letter-spacing:-0.25pt;"> </font>with<font style="letter-spacing:0.4pt;"> </font>any<font style="letter-spacing:-0.4pt;"> </font>new<font style="letter-spacing:0.3pt;"> </font>or<font style="letter-spacing:-0.2pt;"> </font>re<font style="color:#171717;">v</font>ised<font style="letter-spacing:0.3pt;"> </font>financial<font style="letter-spacing:-0.05pt;"> </font>accounting<font style="letter-spacing:0.05pt;"> </font>standards<font style="letter-spacing:-0.5pt;"> </font>pro<font style="color:#171717;">v</font>ided<font style="letter-spacing:0.1pt;"> </font>pursuant<font style="letter-spacing:0.15pt;"> </font>to<font style="letter-spacing:0.5pt;"> </font>Section<font style="letter-spacing:0.6pt;"> </font>13(a)<font style="letter-spacing:-0.9pt;"> </font>of<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:0.05pt;"> </font>E<font style="color:#171717;">x</font>change<font style="letter-spacing:0.05pt;"> </font>Act.<font style="color:#000000;font-size:11pt;"> &#9633;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:20.83%;"></td>
<td style="width:39.49%;"></td>
<td style="width:39.68%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%;"><font style="margin-left:36pt;"></font>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="hdr"></a><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3.01</font><font style="margin-left:36pt;"></font><font style="letter-spacing:0.05pt;">Notic</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">e</font><font style="letter-spacing:0.2pt;">&#160;</font><font style="letter-spacing:0.05pt;">o</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">f&#160;</font><font style="letter-spacing:0.05pt;">Delistin</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">g</font><font style="letter-spacing:0.25pt;">&#160;</font><font style="letter-spacing:0.05pt;">o</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">r</font><font style="letter-spacing:0.05pt;">&#160;Failur</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">e</font><font style="letter-spacing:0.2pt;">&#160;</font><font style="letter-spacing:0.05pt;">t</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">o&#160;</font><font style="letter-spacing:0.05pt;">Satisf</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">y</font><font style="letter-spacing:0.2pt;">&#160;</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">a&#160;</font><font style="letter-spacing:0.05pt;">Continue</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">d</font><font style="letter-spacing:0.35pt;">&#160;</font><font style="letter-spacing:0.05pt;">Listin</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">g</font><font style="letter-spacing:0.2pt;">&#160;</font><font style="letter-spacing:0.05pt;">Rul</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">e</font><font style="letter-spacing:0.1pt;">&#160;</font><font style="letter-spacing:0.05pt;">o</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">r</font><font style="letter-spacing:0.05pt;">&#160;Standard</font><font style="font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">;</font><font style="letter-spacing:0.3pt;">&#160;</font><font style="letter-spacing:0.05pt;">Transfer&#160;of Listing</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 28, 2018, Cytori Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;), received a letter (the &#8220;Notice&#8221;) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) indicating that, based upon the closing bid price of the Company&#8217;s common stock for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2).</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until February 25, 2019, in which to regain compliance. In order to regain compliance with the minimum bid price requirement, the closing bid price of the Company&#8217;s common stock must be at least $1 per share for a minimum of ten consecutive business days during this 180-day period. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period, by effecting a reverse stock split, if necessary. However, if it appears to the Nasdaq Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<font style="letter-spacing:0.05pt;">&#160;</font>Notice<font style="letter-spacing:0.15pt;">&#160;</font>does<font style="letter-spacing:0.05pt;">&#160;</font>not result<font style="letter-spacing:0.1pt;">&#160;</font>in<font style="letter-spacing:-0.05pt;">&#160;</font>the immediate<font style="letter-spacing:0.25pt;">&#160;</font>delisting<font style="letter-spacing:0.2pt;">&#160;</font>of<font style="letter-spacing:-0.05pt;">&#160;</font>the Company&#8217;s<font style="letter-spacing:-0.05pt;">&#160;</font>common<font style="letter-spacing:0.2pt;">&#160;</font>stock<font style="letter-spacing:0.1pt;">&#160;</font>from<font style="letter-spacing:0.05pt;">&#160;</font>the Nasdaq<font style="letter-spacing:0.15pt;"> </font>Capital Market. The<font style="letter-spacing:0.05pt;">&#160;</font>Company<font style="letter-spacing:0.25pt;">&#160;</font>intends<font style="letter-spacing:0.15pt;">&#160;</font>to<font style="letter-spacing:-0.05pt;">&#160;</font>monitor<font style="letter-spacing:0.15pt;">&#160;</font>the closing<font style="letter-spacing:0.15pt;">&#160;</font>bid price<font style="letter-spacing:0.05pt;">&#160;</font>of<font style="letter-spacing:-0.05pt;">&#160;</font>the Company&#8217;s <font style="letter-spacing:0.05pt;">commo</font>n<font style="letter-spacing:0.25pt;"> </font><font style="letter-spacing:0.05pt;">stoc</font>k<font style="letter-spacing:0.15pt;"> </font><font style="letter-spacing:0.05pt;">t</font>o <font style="letter-spacing:0.05pt;">allo</font>w<font style="letter-spacing:0.15pt;"> </font>a <font style="letter-spacing:0.05pt;">reasonabl</font>e<font style="letter-spacing:0.3pt;"> </font><font style="letter-spacing:0.05pt;">perio</font>d<font style="letter-spacing:0.15pt;"> </font><font style="letter-spacing:0.05pt;">fo</font>r<font style="letter-spacing:0.05pt;"> th</font>e <font style="letter-spacing:0.05pt;">pric</font>e<font style="letter-spacing:0.1pt;"> </font><font style="letter-spacing:0.05pt;">t</font>o <font style="letter-spacing:0.05pt;">reboun</font>d<font style="letter-spacing:0.25pt;"> </font><font style="letter-spacing:0.05pt;">fro</font>m<font style="letter-spacing:0.1pt;"> </font><font style="letter-spacing:0.05pt;">it</font>s<font style="letter-spacing:0.05pt;"> recen</font>t<font style="letter-spacing:0.15pt;"> </font><font style="letter-spacing:0.05pt;">declin</font>e<font style="letter-spacing:0.2pt;"> </font><font style="letter-spacing:0.05pt;">bu</font>t<font style="letter-spacing:0.05pt;"> wil</font>l<font style="letter-spacing:0.1pt;"> </font><font style="letter-spacing:0.05pt;">continu</font>e<font style="letter-spacing:0.25pt;"> </font><font style="letter-spacing:0.05pt;">t</font>o <font style="letter-spacing:0.05pt;">consider </font>its<font style="letter-spacing:-0.05pt;"> </font>available<font style="letter-spacing:0.15pt;"> </font>options<font style="letter-spacing:0.1pt;"> </font>to<font style="letter-spacing:-0.1pt;"> </font>regain<font style="letter-spacing:0.05pt;"> </font>compliance.<font style="letter-spacing:0.25pt;"> </font>There<font style="letter-spacing:0.05pt;"> </font>can<font style="letter-spacing:-0.05pt;"> </font>be<font style="letter-spacing:-0.05pt;">&#160;</font>no<font style="letter-spacing:-0.05pt;">&#160;</font>assurance<font style="letter-spacing:0.2pt;">&#160;</font>that the<font style="letter-spacing:-0.05pt;">&#160;</font>Company<font style="letter-spacing:0.2pt;">&#160;</font>will be<font style="letter-spacing:-0.05pt;">&#160;</font>able to<font style="letter-spacing:-0.1pt;">&#160;</font>regain<font style="letter-spacing:0.05pt;">&#160;</font>compliance<font style="letter-spacing:0.25pt;">&#160;</font>with the minimum<font style="letter-spacing:0.2pt;">&#160;</font>bid<font style="letter-spacing:-0.05pt;">&#160;</font>price requirement<font style="letter-spacing:0.3pt;"> </font>or<font style="letter-spacing:-0.05pt;"> </font>maintain<font style="letter-spacing:0.2pt;"> </font>compliance<font style="letter-spacing:0.3pt;">&#160;</font>with<font style="letter-spacing:0.05pt;">&#160;</font>the other<font style="letter-spacing:0.05pt;">&#160;</font>listing<font style="letter-spacing:0.1pt;">&#160;</font>requirements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:88.67%;">
<tr>
<td style="width:44.33%;"></td>
<td style="width:44.33%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:&nbsp;&nbsp;August 31, 2018</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Tiago Girao</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tiago Girao</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VP Finance and Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p></body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "cytx-8k_20180831.htm", "description": "8-K", "secsgml_size_bytes": 36036}]
{"company-data": {"conformed-name": "CYTORI THERAPEUTICS, INC.", "cik": "0001095981", "assigned-sic": "3841", "irs-number": "330827593", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-34375", "film-number": "181050604"}, "business-address": {"street1": "3020 CALLAN ROAD", "city": "SAN DIEGO", "state": "CA", "zip": "92121", "phone": "8584580900"}, "mail-address": {"street1": "3020 CALLAN ROAD", "city": "SAN DIEGO", "state": "CA", "zip": "92121"}, "former-company": {"former-conformed-name": "MACROPORE INC", "date-changed": "20010320"}}
cytx-8k_20180831.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
August 28, 2018
CYTORI THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-34375
33-0827593
(State or Other Jurisdiction of Incorporation)
(Commission File
Number)
(I.R.S. Employer Identification Number)
3020 Callan Road, San Diego, California 92121
(Address of principal executive offices, with zip code)
(858) 458-0900
(Registrant's telephone number, including area code)
n/a
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
□
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
□
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
□
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
□
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by
check
mark whether
the
registrant
is
a
n
emerging
growth
company
as
defined
in as
defined
in
Rule
405
of the
Securities
Act
of
1933
(§
230.405
of
this
chapter)
or
Rule
12b-2
of
the
Securities
Exchange
Act
of
1934
(§
240.12b-2
of
this
chapter).
Emerging
growth
company
□
If an emerging growth company,
indi
c
a
te
by
check
mark
if
the
registrant
has
elected
not to use the
e
x
tended
transition
period
for complying
with
any
new
or
re
v
ised
financial
accounting
standards
pro
v
ided
pursuant
to
Section
13(a)
of
the
E
x
change
Act.
□
Item 3.01
Notic
e
o
f
Delistin
g
o
r
Failur
e
t
o
Satisf
y
a
Continue
d
Listin
g
Rul
e
o
r
Standard
;
Transfer of Listing
On August 28, 2018, Cytori Therapeutics, Inc., a Delaware corporation (the "Company"), received a letter (the "Notice") from the Listing Qualifications staff of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based upon the closing bid price of the Company's common stock for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until February 25, 2019, in which to regain compliance. In order to regain compliance with the minimum bid price requirement, the closing bid price of the Company's common stock must be at least $1 per share for a minimum of ten consecutive business days during this 180-day period. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period, by effecting a reverse stock split, if necessary. However, if it appears to the Nasdaq Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.
The
Notice
does
not result
in
the immediate
delisting
of
the Company's
common
stock
from
the Nasdaq
Capital Market. The
Company
intends
to
monitor
the closing
bid price
of
the Company's
commo
n
stoc
k
t
o
allo
w
a
reasonabl
e
perio
d
fo
r
th
e
pric
e
t
o
reboun
d
fro
m
it
s
recen
t
declin
e
bu
t
wil
l
continu
e
t
o
consider
its
available
options
to
regain
compliance.
There
can
be
no
assurance
that the
Company
will be
able to
regain
compliance
with the minimum
bid
price requirement
or
maintain
compliance
with
the other
listing
requirements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CYTORI THERAPEUTICS, INC.
Date:  August 31, 2018
By: /s/ Tiago Girao
Tiago Girao
VP Finance and Chief Financial Officer